The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
Open accessAbstract
The effect of amiodarone on survival was assessed in patients with hypertrophic cardiomyopathy and ventricular tachycardia in a drug trial with historical controls. During 1976 and 1977, 24 hour (seven) or 48 hour (79) electrocardiographic monitoring was performed in 86 consecutive patients; 24 had ventricular tachycardia and received conventional antiarrhythmic agents. Nineteen clinical, echocardiographic, and haemodynamic features were assessed. Seven patients died suddenly during follow up of three years; of these, five had continued to have ventricular tachycardia and two had no documented ventricular tachycardia. During 1978 and 1979, ventricular tachycardia was detected during 48 hour electrocardiographic monitoring in 21 of the next 82 consecutive patients with hypertrophic cardiomyopathy. They received amiodarone (150-400 mg/day, median 300); ventricular tachycardia was suppressed in all during repeat 48 hour electrocardiographic examination. Two patients died suddenly during a three year follow up, but neither belonged to the amiodarone treated group with ventricular tachycardia. The clinical and haemodynamic variables were similar in patients taking amiodarone and conventional agents. The fact that control of ventricular arrhythmia with amiodarone is significantly associated with improved survival suggests that amiodarone may prevent sudden death in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical methods in medical research
Menduke, H. (1972) · Journal of the Franklin Institute · doi:10.1016/0016-0032(72)90050-6 · Cited by 1,263
ASYMMETRICAL HYPERTROPHY OF THE HEART IN YOUNG ADULTS
Teare, D. (1958) · Heart · doi:10.1136/hrt.20.1.1 · Cited by 1,081
FRANK, S., & BRAUNWALD, E. (1968) · Circulation · doi:10.1161/01.cir.37.5.759 · Cited by 660
McKenna, W., Deanfield, J., Faruqui, A., England, D., Oakley, C., & Goodwin, J. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90535-x · Cited by 630
Self-citationMaron, B. J., Savage, D. D., Wolfson, J. K., & Epstein, S. E. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90604-4 · Cited by 495
Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis.
McKenna, W. J., England, D., Doi, Y. L., Deanfield, J. E., Oakley, C., & Goodwin, J. F. (1981) · Heart · doi:10.1136/hrt.46.2.168 · Cited by 423
Self-citationShapiro, L. M., & McKenna, W. J. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80269-1 · Cited by 325
Self-citationSavage, D. D., Seides, S. F., Maron, B. J., Myers, D. J., & Epstein, S. E. (1979) · Circulation · doi:10.1161/01.cir.59.5.866 · Cited by 253
Maron, B. J., Roberts, W. C., Edwards, J. E., McAllister, H. A., Foley, D. D., & Epstein, S. E. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90717-8 · Cited by 218
Amiodarone for long-term management of patients with hypertrophic cardiomyopathy
McKenna, W. J., Harris, L., Rowland, E., Kleinebenne, A., KRIKLER, D. M., Oakley, C. M., & Goodwin, J. F. (1984) · The American Journal of Cardiology · doi:10.1016/s0002-9149(84)80212-x · Cited by 135
Self-citationArrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment.
McKenna, W. J., Harris, L., Perez, G., KRIKLER, D. M., Oakley, C. M., & Goodwin, J. F. (1981) · Heart · doi:10.1136/hrt.46.2.173 · Cited by 99
Self-citationAmiodarone in the treatment of refractory supraventricular and ventricular arrhythmias
Wheeler, P. J., Ingram, D. V., Puritz, R., & Chamberlain, D. A. (1979) · Postgraduate Medical Journal · doi:10.1136/pgmj.55.639.1 · Cited by 71
The natural history of hypertrophic cardiomyopathy
McKenna, W. J., & Goodwin, J. F. (1981) · Current Problems in Cardiology · doi:10.1016/0146-2806(81)90015-3 · Cited by 50
Self-citation
Cited by
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Self-citationPriori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
Zeppenfeld, K., Tfelt-Hansen, J., de Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,140
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224
Metadata
- Authors
- McKenna, W. J., Oakley, C. M., Krikler, D. M., & Goodwin, J. F.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 1985-04-01
- Volume
- 53
- Issue
- 4
- Pages
- 412-416
- ISSN
- 1355-6037 (ISSN-L)
- OpenAlex
- W2130878870
- Cited by
- 322
- References
- 13
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.